HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McGowan, F. X. Articles by Siewers, R. D. Search for Related Content PubMed PubMed Citation Articles by McGowan, F. X., Jr Articles by Siewers, R. D.

The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 968-977, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Cardiopulmonary bypass significantly reduces surfactant activity in children

FX McGowan Jr, M Ikegami, PJ del Nido, EK Motoyama, G Kurland, PJ Davis and RD Siewers
Department of Anesthesiology/Critical Care Medicine, University of Pittsburgh School of Medicine, Pa.

Lung injury remains an important problem after cardiopulmonary bypass. The contribution of altered surfactant concentration or activity to pulmonary dysfunction after cardiopulmonary bypass is unclear. Recent evidence indicates that alveolar surfactant exists in specific aggregate forms that differ with respect to density, phospholipid composition, and function. A transition from surface active, higher density, large aggregates of surfactant to lower density, small aggregates that possess reduced surface activity has been demonstrated after experimental lung injury. The purpose of the present study was to examine surfactant aggregate fractions before and after bypass in children. Twelve acyanotic patients, aged 2 to 12 years, underwent intraoperative pulmonary function testing followed by bronchoalveolar lavage before incision and approximately 1 hour after termination of cardiopulmonary bypass. Saturated phosphatidylcholine pool sizes and total protein content of the small- and large-aggregate fractions of bronchoalveolar lavage fluid were determined. One hour after termination of cardiopulmonary bypass, the ratio of saturated phosphatidylcholine in small-aggregate as compared with that in large- aggregate fractions increased (mean +/- standard error) from 0.19 +/- 0.03 to 0.37 +/- 0.07 (p < 0.02), as did the ratio of saturated phosphatidylcholine to protein in the small-aggregate fraction (from 0.04 +/- 0.01 to 0.08 +/- 0.02, p < 0.05). Reductions in forced vital capacity (-19% +/- 5%), inspiratory capacity (-15% +/- 3%), and small airway flow rates (-32% +/- 6%) were also observed after bypass. These changes were accompanied by a fivefold increase in alveolar polymorphonuclear leukocyte content. The present study suggests that cardiopulmonary bypass of moderate duration in relatively healthy children is associated with surfactant changes that are similar in type and magnitude to those observed in experimental lung injury.

This article has been cited by other articles:

				J. W. Hammon Extracorporeal Circulation: Organ Damage Card. Surg. Adult, January 1, 2008; 3(2008): 389 - 414. [Full Text]

				J. M. Dodd-o, L. E. Welsh, J. D. Salazar, P. L. Walinsky, E. A. Peck, J. G. Shake, D. J. Caparrelli, R. C. Ziegelstein, J. L. Zweier, W. A. Baumgartner, et al. Effect of NADPH oxidase inhibition on cardiopulmonary bypass-induced lung injury Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H927 - H936. [Abstract] [Full Text] [PDF]

				J. M. Dodd-o, L. E. Welsh, J. D. Salazar, P. L. Walinsky, E. A. Peck, J. G. Shake, D. J. Caparrelli, B. T. Bethea, S. M. Cattaneo, W. A. Baumgartner, et al. Effect of bronchial artery blood flow on cardiopulmonary bypass-induced lung injury Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H693 - H700. [Abstract] [Full Text] [PDF]

				J. W. Hammon Jr. and L. H. Edmunds Jr. Extracorporeal Circulation: Organ Damage Card. Surg. Adult, January 1, 2003; 2(2003): 361 - 388. [Full Text]

				M. Guler, K. Kirali, M. E. Toker, N. Bozbuga, S. N. Omeroglu, E. Akinci, and C. Yakut Different CABG methods in patients with chronic obstructive pulmonary disease Ann. Thorac. Surg., January 1, 2001; 71(1): 152 - 157. [Abstract] [Full Text] [PDF]

				K. J. Millar, P. A. Dargaville, and M. South Pulmonary surfactant and cardiopulmonary bypass in infants J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 192 - 192. [Full Text]

				D. A. Paul, J. S. Greenspan, D. A. Davis, P. Russo, and M. J. Antunes Pulmonary surfactant and cardiopulmonary bypass in infants J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 192 - 193. [Full Text]

				M. Griese, C. Wilnhammer, S. Jansen, and C. Rinker CARDIOPULMONARY BYPASS REDUCES PULMONARY SURFACTANT ACTIVITY IN INFANTS J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 237 - 244. [Abstract] [Full Text] [PDF]

				D. A. Paul, J. S. Greenspan, D. A. Davis, P. Russo, and M. J. Antunes THE ROLE OF CARDIOPULMONARY BYPASS AND SURFACTANT IN PULMONARY DECOMPENSATION AFTER SURGERY FOR CONGENITAL HEART DISEASE J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 1025 - 1026. [Full Text] [PDF]

				J. López-Herce, N. de Lucas, A. Carrillo, A. Bustinza, and R. Moral Surfactant treatment for acute respiratory distress syndrome Arch. Dis. Child., March 1, 1999; 80(3): 248 - 252. [Abstract] [Full Text]

				L. A. Skaryak, A. J. Lodge, P. M. Kirshbom, L. R. DiBernardo, B. G. Wilson, J. N. Meliones, R. M. Ungerleider, and J. W. Gaynor Low-Flow Cardiopulmonary Bypass Produces Greater Pulmonary Dysfunction Than Circulatory Arrest Ann. Thorac. Surg., November 1, 1996; 62(5): 1284 - 1288. [Abstract] [Full Text]